A systematic review of the effectiveness of policies restricting access to pregabalin

BACKGROUND: Formularies often employ restriction policies to reduce pharmacy costs. Pregabalin, an alpha-2-delta ligand, is approved for treatment of fibromyalgia (FM); neuropathic pain (NeP) due to postherpetic neuralgia (PHN), diabetic peripheral neuropathy (pDPN), spinal cord injury; and as adjun...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Stacey, Brett R., Liss, Jonathan, Behar, Regina, Sadosky, Alesia, Parsons, Bruce, Masters, Elizabeth T., Hlavacek, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6389065/
https://ncbi.nlm.nih.gov/pubmed/28841868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2503-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados